SOPHiA GENETICS (SOPH) Revenue (2020 - 2026)

SOPHiA GENETICS has disclosed Revenue across 7 years of filings, most recently posting $23.3 million for Q2 2026.

• In Q2 2026, Revenue rose 27.22% year-over-year to $23.3 million; the TTM figure through Jun 2026 stood at $86.2 million (up 23.65% YoY), while the FY2025 annual figure was $77.3 million, up 18.56% from the prior year.
• Revenue came in at $23.3 million for Q2 2026 at SOPHiA GENETICS, up from $21.7 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $23.3 million in Q2 2026 to a low of $10.9 million in Q1 2022.
• Average Revenue over 5 years is $16.5 million, with a median of $16.1 million recorded in 2023.
• Year-over-year, Revenue soared 39.96% in 2023 and decreased 2.76% in 2024.
• Over 5 years, Revenue stood at $13.4 million in 2022, then climbed by 27.38% to $17.0 million in 2023, then rose by 4.02% to $17.7 million in 2024, then grew by 22.41% to $21.7 million in 2025, then rose by 7.38% to $23.3 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $23.3 million in Q2 2026, $21.7 million in Q1 2026, and $21.7 million in Q4 2025.